FDA Inspection
Accolade Pharma USA Inc.Accolade Pharma USA Inc. – FDA Inspection, Jul 31, 2026
Record Details
This FDA Inspection record concerns Accolade Pharma USA Inc., with an inspection on July 31, 2026, issued by the Los Angeles District Office, covering foods & cosmetics.
View Company Profile
ID · 90860f56-9e2e-4048-97e5-0f88b19f6725
Inspection Facts
- Inspection number
- 1329358
- FDA center
- Foods & Cosmetics
- Project area
- Food Composition, Standards, Labeling and Econ
- Outcome
- Form 483 issued
FDA Citations
10- 21 CFR 111.103Written procedures - establish; quality control operations
- 21 CFR 111.153Written procedures - establish; components
- 21 CFR 111.205(a)Master manufacturing record - prepared
- 21 CFR 111.25Equipment - establish written procedures
- 21 CFR 111.260Batch record - required information
- 21 CFR 111.303Written procedures - establish; laboratory
- 21 CFR 111.403Written procedures - establish; packaging & labeling
- 21 CFR 111.70(b)Specifications - components
- 21 CFR 111.70(e)Specifications - finished dietary supplement
- 21 CFR 111.75(c)Specifications met - verify; finished batch
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Accolade Pharma USA Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 26, 2021 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| August 14, 2018 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| December 29, 2016 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Accolade Pharma USA Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.